Acucela Inc. (TOKYO:4589), a clinical-stage biotechnology company focused on discovering and developing novel therapeutics to treat the progression of sight-threatening ophthalmic diseases, today announced that Brian O’Callaghan, Acucela’s President and Chief Operating Officer (COO), will assume the role of Chief Executive Officer (CEO), along with continuing to serve as Interim Chief Financial Officer (CFO).
Help employers find you! Check out all the jobs and post your resume.
